 ROCHESTER, Mich., July 23, 2020 GLOBE NEWSWIRE -- OptimizeRx Corp. Nasdaq: OPRX, a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Wednesday, August 5, 2020 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2020. The financial results will be issued in a press release prior to the call. OptimizeRx management will host the call, followed by a question and answer period.Date: Wednesday, August 5, 2020 Time: 4:30 p.m. Eastern time 1:30 p.m. Pacific time Toll-free dial-in number: 1-866-248-8441 International dial-in number: 1-323-289-6576 Conference ID: 1161129Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact CMA at 1-949-432-7566.A replay of the call will be available after 7:30 p.m. Eastern time on the same day through August 26, 2020, as well as available for replay via the Investors section of the OptimizeRx website at optimizerx.cominvestors.Toll-free replay number: 1-844-512-2921 International replay number: 1-412-317-6671 Replay ID: 1161129About OptimizeRx OptimizeRx Corporation NASDAQ: OPRX is a digital health company that facilitates communication at the point-of-care among all stakeholders in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables affordability, patient adherence and care management. OptimizeRxs network reaches more than 60 of U.S. ambulatory providers, delivering therapeutic support on specialty medications and patient financial assistance directly within a providers workflow through leading electronic health platforms. OptimizeRxs fully integrated platform supports the real-time exchange of information, improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes. For more information, follow the company on Twitter, LinkedIn or visit Important Cautions Regarding Forward Looking Statements This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words estimate, possible and seeking and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.Company Contact Doug Baker, CFO Tel 248 651-6568 x807 Contact Maira Alejandra, Media Relations Manager Tel 754 245-7070 Relations Contact Ron Both or Grant Stude CMA Investor Relations Tel 949 432-7557 